However, while the specific DNA methylation alterations conferred by TET2 and DNMT3A mutations have been described in human cancer and in cell lines and mouse models with gene inactivation4,9,12–15, somatic mutations in these genes have not been investigated in vivo in hematologically healthy human individuals. The gene discussed is TET2; the disease is cancer.